You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 131 No. 2, February 1996 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati
What's this?

Correcting Prolonged Bleeding During Renal Transplantation With Estrogen or Plasma

Gwendolyn L. Boyd, MD; Arnold G. Diethelm, MD; Simon Gelman, MD, PhD; Rebecca Langner, MSN; David Laskow, MD; Mark Deierhoi, MD; W. Henry Barber, MD, DPhil

Arch Surg. 1996;131(2):160-165.


Abstract

Objective
To determine the efficacy and relative effectiveness of conjugated entrogens (CE) and freshfrozen plasma (FFP) in normalizing prolonged preoperative bleeding times during renal transplantation.

Design
Prospective, randomized trial.

Setting
A university regional referral center for transplantation.

Patients
Patients scheduled for renal transplantation with preoperative bleeding times greater than 10 minutes (normal, <7 minutes) following informed consent were asked to participate in the randomized protocol. Those with bleeding times of 8 to 9.5 minutes were asked, following informed consent, to be a control group receiving neither CE nor FFP.

Interventions
Following induction of anesthesia and drawing of baseline laboratory tests, patients were administered randomly, using a table of random numbers, either 50 mg of CE or 2 U of FFP.

Main Outcome Measures
Bleeding time measurements and other laboratory tests were repeated at the end of surgery as well as at 24 and 48 hours postoperatively.

Results
Treatment with CE and FFP decreased the patients' bleeding times from 16.68±0.8 (SEM) and 17.13±0.85 minutes to 7.67±0.79 (P<.001) and 10.50±1.27 minutes (P<.001), respectively, by the end of surgery. At 24 and 48 hours postoperatively, the CE group had bleeding times of 9.77±0.99 and 9.81± 1.24 minutes (P<.001 for both), respectively, whereas the FFP group bleeding times were 12.76±1.57 (P=.003) and 12.14±1.56 minutes (P=.001), respectively. There were no statistical differences for the control group compared with baseline either at the end of surgery or at 24 hours.

Conclusions
Although both CE and FFP significantly decreased prolonged preoperative bleeding times during renal transplantation, CE might be preferred because of lower risk and cost, as well as a longer duration of action.

(Arch Surg. 1996;131:160-165)



Author Affiliations

From the Departments of Anesthesiology (Drs Boyd and Gelman and Ms Langner) and Surgery (Drs Diethelm, Laskow, Deierhoi, and Barber), The University of Alabama at Birmingham.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Discontinuation of the Bleeding Time Test without Detectable Adverse Clinical Impact
Lehman et al.
Clin. Chem. 2001;47:1204-1211.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1996 American Medical Association. All Rights Reserved.